The Pharmacy Times® Alzheimer Disease Resource Center is a comprehensive resource for clinical news and expert insights on treatments for Alzheimer disease.
February 17th 2025
Pharmacists can support patients with treatment education, monitoring, and adherence, helping to overcome challenges posed by cognitive decline.
FDA Grants Approval to Generic Extended-Release Memantine/Donepezil and Everolimus
Published: January 23rd 2025 | Updated: January 23rd 2025Memantine/donepezil and everolimus are used to treat dementia of the Alzheimer type and tuberous sclerosis complex-associated subependymal giant cell astrocytoma, respectively.
Read More
Pharmacists Can Help Patients Navigate Current Treatment Landscape of Alzheimer Disease
January 10th 2025The pharmacist’s role includes educating and making recommendations, collaborating with health care professionals, and observing early signs of cognitive impairment in patients during interactions.
Read More